| Financial Year |
March 31 2023 |
| Monetary Funds |
384,448,083.62 |
| Held-for-trading Financial Assets |
864,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
417,642,437.05 |
| Advances to Suppliers |
36,609,783.33 |
| Other Receivables |
30,505,861.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
189,424,582.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,564,042.32 |
| Total Current Assets |
1,967,874,236.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
188,324,638.50 |
| Under-construction Projects |
6,987,544.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,259,412.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,362,158.81 |
| Deferred Income Tax Assets |
15,392,371.23 |
| Other Non-Current Assets |
2,138,887.18 |
| Sub-Total of Non-Current Assets |
378,613,409.39 |
| Total Assets |
2,346,487,645.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,597,094.02 |
| Accounts Payable |
60,655,489.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,733,893.57 |
| Taxes Payable |
5,860,763.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,550,316.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,952,094.04 |
| Other Current Liabilities |
2,957,046.83 |
| Sub-Total of Current Liabilities |
244,022,660.30 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,736,095.54 |
| Deferred Income Tax Liabilities |
1,761,023.74 |
| Other Non-Current Liabilities |
7,060,140.37 |
| Sub-Total of Non-Current Liabilities |
45,434,404.53 |
| Total Liabilities |
289,457,064.83 |
| Paid-In Capital(Or Share Stock) |
238,400,000.00 |
| Capital Surplus |
831,157,350.74 |
| Surplus Reserve |
103,914,802.56 |
| LESS:Treasury Stock |
93,216,082.57 |
| Undistributed Profits |
976,774,510.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,057,030,580.86 |
| Owner's Equity（Stockholder's Equity） |
2,057,030,580.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,346,487,645.69 |
